The ACME Laboratories Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	2,456	1,927	1,752	1,455	1,239	1,594
Short-Term Investments	134.35	114.92	56.32	50.45	48.14	180.12
Cash & Short-Term Investments	2,590	2,042	1,808	1,506	1,287	1,774
Cash Growth	-1.72%	12.95%	20.09%	17.00%	-27.45%	-15.60%
Accounts Receivable	3,702	3,614	3,259	2,705	2,236	2,216
Other Receivables	24.82	120.52	20.13	19.89	19.81	19.93
Receivables	3,727	3,734	3,279	2,725	2,256	2,236
Inventory	12,069	12,588	11,871	10,234	7,879	5,124
Prepaid Expenses	-	23.54	17.36	15.61	14.01	13.09
Other Current Assets	7,836	7,126	6,886	6,655	5,907	6,193
Total Current Assets	26,222	25,515	23,863	21,136	17,343	15,341
Property, Plant & Equipment	33,181	32,849	31,729	29,243	25,599	25,100
Long-Term Investments	30.2	30.38	30.2	31.52	32.88	35.51
Other Intangible Assets	101.63	-	-	-	0	0.02
Total Assets	59,535	58,394	55,622	50,410	42,975	40,476
Accounts Payable	529.23	514.07	603.67	490.89	449	350.25
Accrued Expenses	677.17	481.93	600.01	553.26	574.63	508.59
Short-Term Debt	14,675	15,612	15,053	12,523	9,383	7,141
Current Portion of Long-Term Debt	1,955	2,123	2,115	2,054	2,328	2,601
Current Portion of Leases	26.95	27.86	21.49	21.86	22.33	14.27
Current Income Taxes Payable	4,021	3,276	3,022	3,255	2,661	2,856
Current Unearned Revenue	-	64.32	111.83	48.2	14.46	8.33
Other Current Liabilities	3.45	3.8	3.83	6.51	4.38	7.23
Total Current Liabilities	21,887	22,104	21,531	18,953	15,438	13,487
Long-Term Debt	7,031	7,075	6,753	6,168	4,175	5,442
Long-Term Leases	69.49	77.4	44.87	62.29	73.2	62.88
Pension & Post-Retirement Benefits	1,834	1,630	1,451	1,028	691.75	500.46
Long-Term Deferred Tax Liabilities	725.03	767.68	790.57	903.14	907.59	873.54
Total Liabilities	31,546	31,654	30,570	27,115	21,285	20,366
Common Stock	2,116	2,116	2,116	2,116	2,116	2,116
Additional Paid-In Capital	5,128	5,128	5,128	5,128	5,128	5,128
Retained Earnings	15,850	14,567	12,833	11,029	9,304	7,675
Comprehensive Income & Other	4,896	4,930	4,975	5,022	5,142	5,192
Shareholders' Equity	27,989	26,740	25,052	23,295	21,690	20,111
Total Liabilities & Equity	59,535	58,394	55,622	50,410	42,975	40,476
Total Debt	23,756	24,915	23,988	20,829	15,982	15,262
Net Cash (Debt)	-21,166	-22,873	-22,179	-19,324	-14,694	-13,488
Net Cash Per Share	-100.01	-108.09	-104.82	-91.32	-69.44	-63.74
Filing Date Shares Outstanding	211.48	211.6	211.6	211.6	211.6	211.6
Total Common Shares Outstanding	211.48	211.6	211.6	211.6	211.6	211.6
Working Capital	4,335	3,411	2,332	2,182	1,905	1,853
Book Value Per Share	132.35	126.37	118.39	110.09	102.50	95.04
Tangible Book Value	27,888	26,740	25,052	23,295	21,690	20,111
Tangible Book Value Per Share	131.87	126.37	118.39	110.09	102.50	95.04
Land	-	5,547	5,419	5,233	5,228	4,967
Buildings	-	14,306	12,236	9,649	8,112	6,770
Machinery	-	16,687	17,346	16,538	13,018	12,934
Construction In Progress	-	3,195	3,756	4,367	4,820	5,442